To determine which component of the MMR pathway should be targeted in neuroblastoma tumors, we mined The Cancer Genome Atlas (TCGA) database to investigate the expression of MMR genes in MSI-h colorectal and stomach adenocarcinoma patients. The gene discussed is MRC1; the disease is gastric adenocarcinoma.